Abstract
Pasireotide (PAS) is an effective treatment for Cushing's disease (CD) but its use is burdened by an associated high incidence of diabetes mellitus (DM). The aim of this study was to examine the effect of a single subcutaneous injection of PAS on glucose metabolism in CD, and to identify predictors of DM onset. Fifteen patients with CD (13 females, 2 males; median age 43 years [IQR 34-50]) were submitted to an acute PAS test (600 µg s.c.), measuring glucose, insulin, C-peptide, GIP, glucagon, GLP-1, ACTH, and cortisol at the baseline and every 30 min for 2 h. Then they were treated twice daily with PAS 600 µg, and followed up with clinical and hormone assessments for a median of 6 months [2-13]. PAS prompted a significant decrease in all hormonal parameters considered except for glycemia, which increased (as expected), reaching the highest value at 120' (p < 0.0001). Overall, 9/15 patients developed DM within 2 months of starting PAS therapy. There were no differences in age, weight, visceral adiposity, HOMA index, fasting glucose or severity of CD between patients who developed DM and those who did not. Baseline fasting glucagon levels were higher in the DM patients (17.95 [12.45-20.54] vs. 10.53 [8.11-12.33] pmol/L, p = 0.025...Continue Reading
References
Jul 1, 1985·Diabetologia·D R MatthewsR C Turner
Jul 8, 1995·Lancet·M H DuncanJ Alaghband-Zadeh
Jan 1, 1993·The Journal of Clinical Investigation·M A NauckW Creutzfeldt
May 1, 1996·Diabetes·M Toft-NielsonJ J Holst
Jan 19, 1999·Diabetes·U KumarY C Patel
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·M B Toft-NielsenJ J Holst
May 1, 2002·European Journal of Endocrinology·C BrunsG Weckbecker
Aug 2, 2003·Psychoneuroendocrinology·Jens C PruessnerDirk H Hellhammer
Dec 7, 2007·Diabetes·Kirsten VollmerJuris J Meier
Feb 23, 2008·Diabetologia·P V HøjbergS Madsbad
Mar 4, 2008·The Journal of Endocrinology·K Alexander H IwenJohannes Klein
Jan 14, 2010·Diabetes Care·Marco C AmatoUNKNOWN AlkaMeSy Study Group
Jul 1, 2010·Diabetes Care·Xuanping ZhangAnn L Albright
Nov 26, 2010·Vitamins and Hormones·Bo AhrénCarolyn F Deacon
Nov 4, 2011·European Journal of Endocrinology·Laura TrementinoGiorgio Arnaldi
Mar 9, 2012·The New England Journal of Medicine·Annamaria ColaoUNKNOWN Pasireotide B2305 Study Group
Jan 4, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Apr 9, 2013·Pituitary·Annamaria ColaoFelipe F Casanueva
May 21, 2013·Cell Metabolism·Jonathan E Campbell, Daniel J Drucker
Jun 5, 2013·The Journal of Clinical Endocrinology and Metabolism·Robert R HenrySunder Mudaliar
Jan 28, 2014·Diabetes Research and Clinical Practice·Astrid BreitschaftGeorg Golor
Feb 19, 2014·Clinical Endocrinology·Rosario PivonelloUNKNOWN Pasireotide B2305 Study Group
Jun 22, 2014·Pituitary·Laura TrementinoGiorgio Arnaldi
Dec 17, 2014·Endocrine·L TrementinoG Arnaldi
Apr 9, 2015·Nature Reviews. Endocrinology·Jonathan E Campbell, Daniel J Drucker
Jul 30, 2015·The Journal of Clinical Endocrinology and Metabolism·Lynnette K NiemanUNKNOWN Endocrine Society
Jan 1, 2016·Journal of Endocrinological Investigation·M G BaroniA Avogaro
Mar 12, 2016·Endocrine·Valentina GuarnottaCarla Giordano
Apr 30, 2016·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·L TrementinoG Arnaldi
Apr 4, 2017·Endocrine Reviews·Carla ScaroniMarco Boscaro
Jun 10, 2017·Endocrine·S PetersennB M K Biller
Jan 9, 2018·Mayo Clinic Proceedings·Sofie HædersdalTina Vilsbøll
Jun 20, 2018·Frontiers in Endocrinology·Mattia BarbotCarla Scaroni
Jul 8, 2018·Endocrine·Mattia BarbotCarla Scaroni
Jul 24, 2018·The Lancet. Diabetes & Endocrinology·Richard A FeeldersAndre Lacroix
Apr 6, 2019·Scientific Reports·Vikram Singh ShekhawatAnil Bhansali
Apr 11, 2019·Endocrine·Rosario PivonelloAnnamaria Colao
Jun 6, 2019·Frontiers in Endocrinology·Mattia BarbotCarla Scaroni
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association